Try our corporate solution for free!

Average R&D cost to develop new biopharma compound 2010-2021

Published by
Matej Mikulic,
Nov 7, 2022
This statistic shows the average research and development cost for large and mid-sized biopharma companies to develop a new compound from discovery to market launch from 2010 to 2021. According to the data, average R&D costs showed a decreasing tendency over the last two years.

Average cost to develop a compound for biopharma companies from 2010 to 2021 (in billion U.S. dollars)

Exclusive Premium statistic

You need a Statista Account for unlimited access.

  • Full access to 1m statistics
  • Incl. source references
  • Available to download in PNG, PDF, XLS format
Statista Accounts
View for free

Access to this and all other statistics on 80,000 topics from

$468 USD / Year
$708 USD / Year

© Statista 2023
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

2022

Region

Worldwide

Survey time period

2010 to 2021

Special properties

12 large and 4 mid-to-large biopharma companies by market cap

Supplementary notes

Includes cost for development of a compound from discovery to launch.
Numbers have been rounded.

Citation formats
Statista Accounts: Access All Statistics. Starting from $468 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 USD $39 USD / Month *
in the first 12 months
Professional Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on " Medical biotech industry "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Statistics on Medical biotech industry

Global overview

8

U.S. and European landscape

6

Focus: U.S. companies

8

Research & development

6

Products

5

Funding/M&A/IPOs

6

Compensation in biotech

6

Further related statistics

21

Further Content: You might find this interesting as well

Topics

Biotech drugsGlobal pharmaceutical industryCancer in the U.S.AmgenCoronavirus (COVID-19) vaccines and treatments
Statista Accounts: Access All Statistics. Starting from $468 USD / Year
Learn more about how Statista can support your business.
Menu